The Lancet Profile picture
Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.

May 29, 2021, 6 tweets

#ChronicPain affects over 30% of people worldwide and exerts an enormous personal and economic burden.

A new @TheLancet Series on #ChronicPain presents recent findings across specialties, with implications for health care providers and patients: hubs.li/H0PgfvK0

Thread⬇️

The Series explores 3 types of pain—nociceptive, neuropathic, nociplastic—and the biopsychosocial model of pain—interactions between #chronicpain, biological, psychological, and social factors.

Read an update on burden, best practices, and new advances: hubs.li/H0Pgfv10

Nociplastic pain is a new descriptor of pain arising from abnormal pain signal processing. It applies to a range of conditions, such as fibromyalgia, that lack clear mechanisms or biomarkers—a challenge to diagnose and treat.

Learn more ➡️ hubs.li/H0Pgfv30

Neuromodulation is an expanding area of pain medicine including surgical techniques—deep brain and spinal cord stimulation.

However, their current role in practice is limited—evidence is inconsistent and often weak.

Read more here: hubs.li/H0PgfvZ0

"Chronic pain is real. It deserves to be taken more seriously. And this @TheLancet series explains why."

Read our latest Editorial—Rethinking chronic pain: hubs.li/H0PghNb0

"...the NICE guideline takes an oversimplified approach and presents chronic primary pain as a diagnosis of exclusion..."

Read a linked Comment from @Chris_Eccleston et al—Pragmatic but flawed: the NICE guideline on #ChronicPain: hubs.li/H0Pgpcf0.

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling